Blocknomi
Key Highlights ALPHA3 trial demonstrated 58.3% MRD negativity in cema-cel patients compared to just 16.7% in the observation group Zero instances of cytokine release syndrome or neurotoxicity reported among treated…
Related articles
-
0G and Alibaba plug Qianwen LLM straight into onchain AI agents
Crypto.News Published 21.04.2026 13:49
-
Cow Protocol Halts Trading After Frontend Domain Hijack
Bitcoin.com Published 14.04.2026 18:51
-
Bitcoin Price Prediction: Structural Strength Could Push BTC to $85K Soon
CryptoPotato Published 23.04.2026 05:50
-
WLFI Token Controversy: $5B Collateral Move, Withdrawal Crisis, and Justin Sun Blacklist Claim
Blocknomi Published 12.04.2026 21:49
-
Xi Denies Arming Iran in Trump Letter Exchange
Crypto.News Published 15.04.2026 20:40
-
Bitcoin Resistance at $78K and $83K Could Cap Rally: Schwab
Decrypt Published 21.04.2026 11:00
-
MiniMax Drops State-of-the-Art AI Agent Model—Then Quietly Changes the License
Decrypt Published 13.04.2026 20:24
-
$14B Vanishes From DeFi Ecosystem After KelpDAO Exploit Rocks Lending Markets
Bitcoin.com Published 20.04.2026 20:30